As a downstream effector of TCF/β-catenin signaling in colorectal cancer, loss of PROX1 does not directly affect cell proliferation, but it rather shifts the transcriptional phenotype of colon cancer cells towards more slowly growing adherent cells. Here, PROX1 is linked to malignant colon neoplasm.